Paper Details
- Home
- Paper Details
Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial.
Author: JatGokul Chand, MathewJoseph L, SinghMeenu
Original Abstract of the Article :
BACKGROUND: Montelukast is reported to be beneficial in asthma as add-on therapy to inhaled corticosteroids and may reduce the need for the latter. OBJECTIVE: To evaluate whether a combination of oral montelukast and 200 microg of inhaled budesonide has comparable efficacy to 400 microg of inhaled ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s1081-1206(10)60807-1
データ提供:米国国立医学図書館(NLM)
Inhaled Budesonide vs. Budesonide and Montelukast: A Balancing Act in the Desert of Asthma
Managing asthma can be a delicate dance, requiring careful consideration of treatment options and their impact on patients. This research focuses on the efficacy and safety of budesonide, a commonly used inhaled corticosteroid, in children with moderate persistent asthma. The researchers conducted a randomized controlled trial to compare the effectiveness of budesonide alone versus a combination of budesonide and montelukast, a leukotriene receptor antagonist, in children with moderate persistent asthma. Their findings suggest that budesonide alone may offer better control of asthma symptoms and a lower risk of exacerbations compared to the combination therapy.
The Shifting Sands of Asthma Treatment
This study suggests that budesonide alone may be a more effective and safe treatment option for children with moderate persistent asthma compared to a combination of budesonide and montelukast. The researchers observed a greater frequency of exacerbations in the group receiving montelukast, highlighting the potential risks associated with this combination therapy.
Finding the Oasis of Optimal Asthma Management
This research provides valuable insights into the complex world of asthma management. It emphasizes the importance of carefully considering individual patient needs and the potential risks and benefits of different treatment options. It underscores the need for ongoing research to optimize asthma management strategies and minimize the risk of exacerbations.
Dr. Camel's Conclusion
Just as a camel seeks out the most advantageous path through a vast and unforgiving desert, healthcare providers must carefully choose the most effective treatment strategies for individuals with asthma. This study adds to our understanding of the complexities of asthma management, providing valuable insights for optimizing patient care.
Date :
- Date Completed 2006-11-14
- Date Revised 2021-12-03
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.